Vertex Pharma (VRTX) volatility elevated at 58

Vertex Pharma (Nasdaq: VRTX) is recently down 39c to $37.08 after Piper Jaffray reiterated its Overweight rating and $56 price target. February and July call option implied volatility of 57 is above its 26-week average of 50 according to Track Data, suggesting larger price movement.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
• Microsoft (MSFT) spreader of 2800 contracts of October 455 puts and October 490 calls
• Carnival Corp. (CCL) call put ratio 1 call to 1.1 puts amid price movement